Bioceres Reports Q4 Earnings Amid Business Restructuring and Financial Challenges
Bioceres Crop Solutions Corp. (BIOX) reported its fourth-quarter earnings for fiscal year 2026, highlighting a challenging period marked by an ongoing reconfiguration of its seed business and litigation with creditors. Full-year revenue declined to $238 million, down 18% from the previous year due primarily to lower performance in crop protection and changes within the seed segment. Despite this decline, cost-cutting initiatives helped reduce SG&A expenses by 19%, leading to an adjusted EBITDA of $600,000 for Q4—up significantly from a loss of $9.6 million in the same period last year. The company reported strong growth in its Crop Nutrition segment, with revenue up 36% quarter-over-quarter due to high demand for microbeaded fertilizer products. Management also announced successful debt restructuring efforts totaling over $74.5 million and outlined a path toward improved gross margins of 40% by fiscal year 2027 through portfolio rationalization and operational efficiency improvements.
Topics: adjusted_ebitda debt_reprofiling gross_profit revenue